Eli Lilly Named in Top 20 Most Admired SSOs and GBS for 2022 by SSON

Add bookmark

Eli Lilly Logo

New York, NY - In every industry there are clear, dominant powers that dictate the trajectory of future trends, practices, and standards. SSON has annually evaluated and measured the current state of the shared services, global business services, and outsourcing industry to provide unparalleled insight into modern business. For the sixth year in a row, SSON Research & Analytics (SSON R&A) announced the list of the Most Admired Shared Services Organizations (SSOs) & Global Business Services (GBS) for 2022, and Eli Lilly is among the appointed. 
 
SSON R&A analyzes SSON's cross-channel data from their 180,000 strong community to identify leading SSOs and GBS across the globe and recognize them for their achievements. In doing this, SSON provides objective, unbiased insights to the shared services and GBS community, backed by data-based research and analytics. This annual report full of expert guidance allows organizations to move forward with confidence, addressing their mission-critical priorities with ease and peace of mind amid uncertain corporate and societal landscapes.  
 
Among SSON’s Top 20 Most Admired Shared Services Organizations and Global Business Services for 2022 is Eli Lilly.  This inclusion was a no-brainer for SSON’s Top 20 for Eli Lilly’s commitment to excellence, unmatched eye for innovation, and an unparalleled sense of community.  
 
"Through our various SSON channels, we identify SSOs & GBS that impress us the most in terms of their specific innovations, achievements and value-add. By recognizing them and inviting them to be part of the Top 20 benchmarking study, it provides both the Top 20 and the wider SSON community the invaluable opportunity to benchmark themselves by identifying areas where they excel in and key areas of improvement. The study also sheds light on the latest trends in service delivery, automation and workforce strategy as the industry navigates through the volatile external environment of economic, political and social volatility." Syazana Lim, Senior Analyst, SSON Research & Analytics 
 
Eli Lilly has further been invited to take part in an exclusive benchmarking study that covers various aspects of their enterprise strategy across 36 key metrics in nine categories: Automation, General Finance, HR & Talent, IT, Order to Cash (O2C), Payroll, Procure to Pay (P2P), Record to Report (R2R), and Treasury, including but not limited to the service delivery model, learning and development initiatives, automation strategy, strategic targets, and more.  

  • Sense of Purpose. Our purpose at Lilly is to create medicines that make life better for people around the world. When we fulfil our purpose, we help others fulfil theirs. Lilly, as an organization, wants all our employees to feel they are part of one team with one purpose, which is to be driven by the desire to make a meaningful difference for people to make life better. Our people are behind the value we bring to patients and society, and that is why we actively cultivate a culture of teamwork and inclusion – so everyone can bring their authentic self, diverse ideas, perspective, and experiences. This has been Lilly’s key strong point in retaining Talents and keeping attrition way below market rate.
  • Center our Strategy on Sustainability. Working together, we unite caring with discovery to create medicines that make life better for everyone in your community. It is not just what we do. It is who we are. Hence adaptability and driving an innovation mindset is vital to support the growth of Lilly. As part of GBS organization, continuous improvement is imbedded as part of our DNA. Through our Data Strategy focusing on data mining and analytics, GBS continues to innovate, automate, and accelerate optimization in the right areas to deliver double digit productivity and savings.
  • Growth. Across the GBS Lilly sites, the scope of work has more than doubled in size and has branched out mainly in the non-Finance areas. With the growth trajectory of Lilly focused on new key drug development, the capabilities supporting Pharmaceutical becomes even more vital. GBS has proven to be a strong source of Talent, coupled with the strong ability to deliver continuous Stable Operation while having an impeccable record when it comes to Ethics and Compliance; therefore, GBS is seen as the proven Strategy to deliver Value to our Patients, to our Stakeholders and Lilly organization as a whole.

Through proof of concept, dedication to the craft, and unwavering commitment to innovation, SSON’s purpose-driven vision has come to fruition with the help of Eli Lilly. 
 
Highlights of the benchmarking data and the complete list of metrics are available on SSONetwork and will be presented at SSON’s SSO Week events throughout 2022-2023. 
 
 
## 
 
 
About SSON 
 
SSON is the largest and most established community of shared services, global business services, and outsourcing professionals in the world. Established in 1999, SSON recognized the revolution in business support services as it was happening and realized that a forum was needed through which practitioners could connect on a regional and global basis. SSON operates under four distinct pillars - SSON Digital, SSON Research & Analytics, SSON Events, and Global Business Services Training & Certification.  
 
## 
 
Website: https://www.ssonetwork.com // https://www.sson-analytics.com  
 
LinkedIn: https://www.linkedin.com/company/ssonetwork  
 
Twitter: https://twitter.com/ssonetwork  
 
Facebook: https://www.facebook.com/ssonetwork  
 
For more information or press inquiries, please contact Kaitlin Mansour at kaitlin.mansour@ssonetwork.com or +1 (810) 397-5267 


RECOMMENDED